Surgical Innovations Group Plc  

(Public, LON:SUN)   Watch this stock  
Find more results for SUN
1.81
-0.07 (-3.47%)
Jul 27 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 1.81 - 1.89
52 week 1.02 - 2.19
Open 1.88
Vol / Avg. 229,437.00/249,495.00
Mkt cap 9.10M*
P/E     -
Div/yield     -
EPS 0.00*
Shares 487.09M
Beta     -
Inst. own     -
*GBP

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -4.42% -37.18%
Operating margin -5.12% -36.12%
EBITD margin - 7.63%
Return on average assets -3.04% -21.35%
Return on average equity -6.36% -40.46%
Employees 49 -
CDP Score - -

Address

Clayton Wood House 6 Clayton Wood Bank
LEEDS, LS16 6QZ
United Kingdom - Map
+44-113-2307597 (Phone)
+44-113-2307598 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance

Description

Surgical Innovations Group plc is a United Kingdom-based holding company. The Company is involved in the design, development, manufacture and sale of devices for use in minimally invasive surgery (MIS) and precision engineering (PE) markets. The Company operates through three segments: SI Brand, OEM and PE. The SI Brand segment is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The PE segment is engaged in the research, development, manufacture and sale of precision engineering applications. The Company sells branded products through independent healthcare distributors across the world and owns label products through original equipment manufacturer (OEM) relationships.

Officers and directors

Nigel Foster Rogers Executive Chairman of the Board
Age: 54
Melanie Ross Interim Managing Director
Age: 35
Douglas B. Liversidge CBE Non-Executive Director
Age: 78
Michael John McMahon Non-Executive Director, Chair of the Clinical Advisory Board
Chris Rea Non-Executive Director